Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Unique Importance of Vision Science Research and the National Eye Institute.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics·2026

Same author

Automated detection of giant cell arteritis from temporal artery biopsy specimens using deep learning approaches.

Scientific reports·2026

Same author

Infectious, Immune-Mediated, and Vaccine-Associated Ocular Adverse Events.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics·2025

Same author

Ocular trauma in microgravity: In-flight diagnostics and extraterrestrial strategies for management.

Survey of ophthalmology·2025

Same author

Epiretinal Membranes Associated With Choroidal Melanoma.

Journal of vitreoretinal diseases·2025

Same author

Rising Incidence of Syphilitic Uveitis-Related Hospitalizations in the US.

JAMA ophthalmology·2023

Same journal

Mitochondrial insufficiencies and neuroprotection in glaucoma.

International ophthalmology·2026

Same journal

Accuracy of new-generation intraocular lens formulas in IOL power calculation for cataract extraction combined with vitrectomy.

International ophthalmology·2026

Same journal

Screen time, strained eyes: knowledge and attitudes toward rising screen hours and ocular health among adults aged 20-30 in sri lanka.

International ophthalmology·2026

Same journal

The burden of keratoconjunctivitis sicca in Nigeria: a scoping review of prevalence and risk factors.

International ophthalmology·2026

Same journal

Comparison of visual outcomes of phakic intraocular lens implantation in keratoconus and normal eyes.

International ophthalmology·2026

Same journal

AS-OCT in infectious keratitis: detecting pachymetry-infiltrate discordance.

International ophthalmology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 13, 2026

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

Biologic agents in experimental autoimmune uveitis.

Gian Paolo Giuliari¹, Ama Sadaka, David M Hinkle

¹Centro de Cirugía Oftalmológica (CECOF), Caracas, Venezuela, gpgiuliari@gmail.com.

International Ophthalmology

|March 16, 2013

Summary

This summary is machine-generated.

Experimental uveitis models help study human uveitis pathogenesis. Novel biologic therapies targeting tumor necrosis factor alpha and interleukins show promise for refractory cases.

More Related Videos

Primed Mycobacterial Uveitis (PMU) as a Model for Post-Infectious Uveitis

Primed Mycobacterial Uveitis (PMU) as a Model for Post-Infectious Uveitis

Published on: December 17, 2021

Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues

Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues

Published on: May 8, 2016

Related Experiment Videos

Last Updated: May 13, 2026

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

Primed Mycobacterial Uveitis (PMU) as a Model for Post-Infectious Uveitis

Primed Mycobacterial Uveitis (PMU) as a Model for Post-Infectious Uveitis

Published on: December 17, 2021

Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues

Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues

Published on: May 8, 2016

Area of Science:

Ophthalmology
Immunology
Inflammation Research

Background:

Uveitis pathogenesis is complex and often requires experimental models for study.
Conventional anti-inflammatory and immunomodulatory agents are used to treat uveitis.
Some uveitis cases are refractory to standard treatments, necessitating novel therapeutic approaches.

Purpose of the Study:

To investigate the pathogenesis of human uveitis using experimental models.
To evaluate the therapeutic efficacy of various anti-inflammatory and immunomodulatory agents in uveitis.
To explore advanced treatments for uveitis unresponsive to conventional therapies.

Main Methods:

Development and utilization of experimental uveitis models.
Assessment of anti-inflammatory agents, including corticosteroids.
Investigation of biologic response modifiers, such as monoclonal antibodies targeting tumor necrosis factor alpha and anti-interleukins.

Main Results:

Experimental models aid in understanding uveitis pathogenesis.
Corticosteroids and immunomodulatory agents show therapeutic effects.
Monoclonal antibodies targeting tumor necrosis factor alpha and anti-interleukins are effective in refractory uveitis.

Conclusions:

Experimental uveitis models are crucial for elucidating disease mechanisms.
Biologic agents targeting specific inflammatory pathways offer new treatment options for severe uveitis.
Targeted immunotherapies represent a significant advancement in managing refractory uveitis.